Ederimotide
Ederimotide (WT-1 A1) can be used as a potential target for studying pancreatic cancer[1].
Product Specifications
CAS Number
852243-39-1
Product Name Alternative
WT-1 A1
UNSPSC
12352209
Target
Others
Type
Peptides
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ederimotide.html
Solubility
10 mM in DMSO
Smiles
O=C(N(CCC1)[C@@H]1C(N[C@@H](CC(N)=O)C(N[C@@H](C)C(N(CCC2)[C@@H]2C(N[C@H](C(N[C@H](C(O)=O)CC(C)C)=O)CC(C=C3)=CC=C3O)=O)=O)=O)=O)[C@@H](NC([C@H](CCSC)NC([C@@H](N)CC(C=C4)=CC=C4O)=O)=O)CC5=CC=CC=C5
Molecular Formula
C55H74N10O13S
Molecular Weight
1115.30
References & Citations
[1]WHO Drug Information. International Nonproprietary Names for Pharmaceutical.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MA401N-100 100 µL
SIRPα (V1&V2&V8, not γ) Neutralizing Antibody, Mouse Monoclonal (Clone 10C9-H11), 100 µg
Sign In for Pricing
View Details 
